Filing Flows › Comparisons › TXMD vs GOVX
TherapeuticsMD vs GeoVax Labs: TXMD and GOVX compared
TherapeuticsMD is the larger company: $869K of revenue in its latest quarter (Q2 2026) against $852K for GeoVax Labs (Q2 2025). GeoVax Labs is growing faster (+184% against -9% a year earlier). TherapeuticsMD is more profitable, with an operating margin of -93.9% against -635.8%.
Where the money goes: TXMD and GOVX
TherapeuticsMD (TXMD) · Q2 2026
TherapeuticsMD, Q2 2026: revenue $869K (-9% year over year), operating margin -93.9%, net earnings $155K, operating cash flow $779K. The chart follows the revenue to costs, profit and cash.
GeoVax Labs (GOVX) · Q2 2025
GeoVax Labs, Q2 2025: revenue $852K (+184% year over year), operating margin -635.8%, net loss $5.4M, operating cash flow −$4.3M. The chart follows the revenue to costs, profit and cash.
| TherapeuticsMD (TXMD) | GeoVax Labs (GOVX) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2025 |
| Revenue | $869K | $852K |
| Revenue growth, Y/Y | -9% | +184% |
| Operating margin | -93.9% | -635.8% |
| Net earnings | $155K | −$5.4M |
| Net margin | 17.8% | -630.0% |
| Operating cash flow | $779K | −$4.3M |
Questions
Which is bigger, TherapeuticsMD or GeoVax Labs?
TherapeuticsMD is the larger company: $869K of revenue in its latest quarter (Q2 2026) against $852K for GeoVax Labs (Q2 2025).
Is TherapeuticsMD or GeoVax Labs growing faster?
GeoVax Labs is growing faster (+184% against -9% a year earlier).
Which is more profitable, TherapeuticsMD or GeoVax Labs?
TherapeuticsMD is more profitable, with an operating margin of -93.9% against -635.8%.
More: TherapeuticsMD earnings · how TherapeuticsMD makes money · GeoVax Labs earnings · how GeoVax Labs makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Jul 28, 2025). Fiscal quarters can end on different dates. Not investment advice.